Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (94)

« Back to Publications

The spatiotemporal distribution of human pathogens in ancient Eurasia

Sikora M. et al, (2025), Nature, 643, 1011 - 1019

Immune perturbation by the ileal microbiota in multiple sclerosis.

Jensen LT. and Fugger L., (2025), Proc Natl Acad Sci U S A, 122

A repair pathway lost in multiple sclerosis provides a new drug opportunity.

Jensen LT. et al, (2024), Nat Immunol, 25, 385 - 386

Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases

Lippert AH. et al, (2024), Immunity, 57, 256 - 270.e10

Ancient DNA reveals evolutionary origins of autoimmune diseases.

Barrie W. et al, (2024), Nat Rev Immunol, 24, 85 - 86

Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations.

Barrie W. et al, (2024), Nature, 625, 321 - 328

The selection landscape and genetic legacy of ancient Eurasians.

Irving-Pease EK. et al, (2024), Nature, 625, 312 - 320

Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitors.

Jensen LT. et al, (2023), EBioMedicine, 97

The immunology of multiple sclerosis.

Attfield KE. et al, (2022), Nat Rev Immunol, 22, 734 - 750

Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade

KAUR G. et al, (2022), Nature Communications

Identification of early neurodegenerative pathways in progressive multiple sclerosis

Kaufmann M. et al, (2022), Nature Neuroscience, 25, 944 - 955

MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19

Francis A. et al, (2022), The Lancet Neurology, 21, 217 - 218

Inflammation-related plasma and CSF biomarkers for multiple sclerosis.

Huang J. et al, (2020), Proc Natl Acad Sci U S A, 117, 12952 - 12960

A novel neurodegenerative spectrum disorder in patients with MLKL deficiency.

Faergeman SL. et al, (2020), Cell Death Dis, 11

Identifying cross-disease components of genetic risk across hospital data in the UK Biobank

Cortes A. et al, (2020), Nature Genetics, 52, 126 - 134

Load More

1
2
3
4
5
6
7